Abstract
British Journal of Cancer (2002) 87, 689–689. doi:10.1038/sj.bjc.6600504 www.bjcancer.com
© 2002 Cancer Research UK
Correction to: British Journal of Cancer (2002) 86, 1270. doi:10.1038/sj/bjc/6600232
The authors would like to thank InSight Ltd., Rehovot, Israel for providing them with the anti-heparanase antibody and heparanase cDNA used in the study.
The mentioned reagents are proprietary of InSight.
